Georgios Theocharidis, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Foot | 9 | 2023 | 352 | 2.730 |
Why?
|
| Wound Healing | 11 | 2023 | 2781 | 1.170 |
Why?
|
| Foreign-Body Reaction | 1 | 2023 | 157 | 0.880 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2023 | 1121 | 0.790 |
Why?
|
| Alginates | 1 | 2022 | 250 | 0.770 |
Why?
|
| Fibroblasts | 5 | 2022 | 4143 | 0.760 |
Why?
|
| Autonomic Pathways | 1 | 2019 | 30 | 0.710 |
Why?
|
| Diabetes Mellitus | 6 | 2023 | 5724 | 0.680 |
Why?
|
| Dermis | 2 | 2018 | 207 | 0.670 |
Why?
|
| Skin Ulcer | 1 | 2019 | 118 | 0.650 |
Why?
|
| Skin | 6 | 2023 | 4353 | 0.560 |
Why?
|
| Collagen Type VI | 1 | 2016 | 26 | 0.550 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 1385 | 0.540 |
Why?
|
| Basement Membrane | 1 | 2017 | 356 | 0.540 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 410 | 0.540 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 2183 | 0.500 |
Why?
|
| Neuropeptides | 1 | 2019 | 942 | 0.470 |
Why?
|
| Extracellular Matrix | 2 | 2018 | 1740 | 0.400 |
Why?
|
| Macrophages | 3 | 2022 | 5655 | 0.390 |
Why?
|
| Cell Movement | 4 | 2020 | 5212 | 0.340 |
Why?
|
| Collagen | 1 | 2017 | 2684 | 0.320 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2011 | 0.220 |
Why?
|
| Matrix Metalloproteinase 11 | 1 | 2022 | 14 | 0.210 |
Why?
|
| Elastomers | 1 | 2022 | 70 | 0.210 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2022 | 141 | 0.200 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2022 | 134 | 0.200 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 533 | 0.190 |
Why?
|
| Bandages | 1 | 2022 | 267 | 0.190 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2020 | 91 | 0.190 |
Why?
|
| Keratinocytes | 2 | 2022 | 797 | 0.180 |
Why?
|
| Swine, Miniature | 1 | 2022 | 961 | 0.180 |
Why?
|
| Organic Anion Transporters | 1 | 2020 | 100 | 0.180 |
Why?
|
| Technology | 1 | 2022 | 303 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 627 | 0.160 |
Why?
|
| Skin, Artificial | 1 | 2018 | 90 | 0.150 |
Why?
|
| Exosomes | 1 | 2022 | 412 | 0.150 |
Why?
|
| Keloid | 1 | 2016 | 50 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 1 | 2022 | 1599 | 0.130 |
Why?
|
| Polymers | 1 | 2022 | 1618 | 0.130 |
Why?
|
| Leukocytes | 1 | 2022 | 2039 | 0.110 |
Why?
|
| Animals | 9 | 2023 | 168561 | 0.110 |
Why?
|
| Mice | 7 | 2023 | 81045 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1606 | 0.110 |
Why?
|
| Epidermis | 1 | 2016 | 527 | 0.110 |
Why?
|
| Swine | 1 | 2022 | 5934 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 957 | 0.100 |
Why?
|
| Indoles | 1 | 2019 | 1834 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1969 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2638 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3585 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 3502 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 9410 | 0.080 |
Why?
|
| Humans | 15 | 2023 | 742088 | 0.080 |
Why?
|
| Models, Animal | 1 | 2016 | 2170 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3455 | 0.080 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1728 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2022 | 3731 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2018 | 19223 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 12071 | 0.060 |
Why?
|
| Streptozocin | 1 | 2023 | 193 | 0.050 |
Why?
|
| Therapies, Investigational | 1 | 2023 | 111 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11470 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14554 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14720 | 0.050 |
Why?
|
| Debridement | 1 | 2022 | 492 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2018 | 624 | 0.030 |
Why?
|
| Scalp | 1 | 2018 | 380 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57683 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2023 | 2382 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7153 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 849 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 2006 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 56350 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2715 | 0.030 |
Why?
|
| Mast Cells | 1 | 2019 | 1544 | 0.030 |
Why?
|
| Oxygen | 1 | 2023 | 4169 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3563 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 162944 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2018 | 1877 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 213127 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 213712 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 15994 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10472 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16331 | 0.010 |
Why?
|
| Male | 1 | 2018 | 349538 | 0.000 |
Why?
|